For the year ending 2025-12-31, EW made $6,067,600K in revenue. $1,073,500K in net income. Net profit margin of 17.69%.
| Income Statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net sales | 6,067,600 | 5,439,500 | 6,004,800 | 5,382,400 |
| Cost of sales | 1,334,200 | 1,117,500 | 1,379,800 | 1,080,400 |
| Gross profit | 4,733,400 | 4,322,000 | 4,625,000 | 4,302,000 |
| Selling, general, and administrative expenses | 2,085,200 | 1,789,200 | 1,824,600 | 1,567,600 |
| Research and development expenses | 1,079,200 | 1,053,000 | 1,071,800 | 945,200 |
| Intellectual property agreement and litigation expense (note 3) | - | - | 203,500 | - |
| Intellectual property agreement and certain litigation expenses (note 3) | 325,400 | 40,400 | - | 15,800 |
| Change in fair value of contingent consideration liabilities (note 13) | -12,500 | 0 | -26,200 | -35,800 |
| Restructuring charges, separation costs, and other (note 4) | 19,100 | - | - | - |
| Restructuring charges, separation costs, and other (note4) | - | 61,000 | - | - |
| Intangible assets impairment charges | 40,000 | - | - | - |
| Special charge and separation costs (note4) | - | - | 17,200 | 60,700 |
| Other operating income | 67,200 | 300 | - | - |
| Operating income | 1,264,200 | 1,378,700 | 1,534,100 | 1,748,500 |
| Interest expense | 20,400 | 19,800 | 17,600 | 19,200 |
| Interest income | 168,800 | 120,300 | 67,200 | 35,500 |
| Loss on impairment | 146,900 | - | - | - |
| Other non-operating income, net (note 18) | 7,200 | 68,900 | 14,400 | 2,600 |
| Income from continuing operations before provision for income taxes | 1,272,900 | 1,548,100 | 1,598,100 | 1,767,400 |
| Provision for income taxes (note 19) | 216,900 | 152,100 | 198,700 | 245,500 |
| Net income from continuing operations | 1,056,000 | 1,396,000 | - | - |
| Income from discontinued operations, net of tax | 13,400 | 2,773,700 | - | - |
| Net income | 1,069,400 | 4,169,700 | 1,399,400 | - |
| Less net loss attributable to noncontrolling interest | -4,100 | -4,900 | -3,000 | - |
| Net income | - | - | - | 1,521,900 |
| Net income attributable to edwards lifesciences corporation | 1,073,500 | 4,174,600 | 1,402,400 | - |
| Basic EPS | 1.84 | 6.98 | 2.31 | 2.46 |
| Diluted EPS | 1.83 | 6.97 | 2.3 | 2.44 |
| Basic Average Shares | 584,800,000 | 597,700,000 | 606,700,000 | 619,000,000 |
| Diluted Average Shares | 585,800,000 | 599,300,000 | 609,400,000 | 624,200,000 |
Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (EW)